Rare diseases
Investigational molecules
Locations
Back to Italy9 clinical trials in Taranto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)
ItalyA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
ItalyStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
ItalyStudy of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer
ItalyStudy on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy
ItalyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
ItalyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
ItalyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
ItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on non-small cell lung cancer treatment, specifically evaluating maintenance therapy approaches for unresectable stage III cases. Research explores the effectiveness of immunotherapy following chemo-radiotherapy treatments.
These studies aim to improve long-term survival rates for patients with locally advanced disease.
Comprehensive research program investigating various forms of leukemia, including acute lymphoblastic leukemia and myeloid leukemia in children. Special focus on innovative treatment protocols for specific patient groups, including children with Down Syndrome.
Multiple trial arms evaluate different therapeutic strategies to enhance survival rates and reduce treatment-related complications.
Groundbreaking studies on Rhabdomyosarcoma and Langerhans Cell Histiocytosis, developing comprehensive treatment protocols for both children and adults. Research encompasses various disease stages and risk levels.
These trials aim to establish more effective treatment strategies for rare cancer types, particularly focusing on pediatric cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
